TPST EV/EBITDA
-1.07
-0.06-5.94%
Fri, 17 Jan 2025 23:53:06 GMT
Summary:
As of January 21, 2025, TPST EV/EBITDA is -1.07, with a fall of -0.06 (-5.94%) during the most recent trading day. Over the past year, it has increased by +1.61 (+60.07%). TPST EV/EBITDA is now -262.12% below its all-time high of 0.66.TPST EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -5.9% |
| 1 m1 month | -16.3% |
| 3 m3 months | -39.0% |
| 6 m6 months | +21.3% |
| ytdytd | -10.3% |
| 1 y1 year | +60.1% |
| 5 y5 years | - |
TPST EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.82 | -30.5% | -1.14 | +6.1% |
| 3 m | 3-month | -0.60 | -78.3% | -1.32 | +18.9% |
| 6 m | 6-month | -0.47 | -127.7% | -1.36 | +21.3% |
| 1 y | 1-year | -0.47 | -127.7% | -3.99 | +73.2% |
| 3 y | 3-year | 0.66 | -262.1% | -5.15 | +79.2% |
| 5 y | 5-year | 0.66 | -262.1% | -5.22 | +79.5% |
| alltime | all time | 0.66 | -262.1% | -5.22 | +79.5% |
Tempest Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.07(+10.3%) |
| 2024 | -0.97(-66.3%) |
| Date | Value |
|---|---|
| 2023 | -2.88(+3100.0%) |
| 2022 | -0.09(-25.0%) |
| 2021 | -0.12 |
FAQ
- What is Tempest Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Tempest Therapeutics?
- What is TPST EV/EBITDA year-to-date change?
- What is Tempest Therapeutics EV/EBITDA year-on-year change?
What is Tempest Therapeutics EV/EBITDA?
The current EV/EBITDA of TPST is -1.07
What is the all time high EV/EBITDA for Tempest Therapeutics?
Tempest Therapeutics all-time high EV/EBITDA is 0.66
What is TPST EV/EBITDA year-to-date change?
Tempest Therapeutics EV/EBITDA has changed by -0.10 (-10.31%) since the beginning of the year
What is Tempest Therapeutics EV/EBITDA year-on-year change?
Over the past year, TPST EV/EBITDA has changed by +1.61 (+60.07%)